BioMarin Pharmaceutical Inc. (BMV:BMRN)
980.00
0.00 (0.00%)
At close: Jan 27, 2026
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 190.85 billion as of February 10, 2026. Its market cap has decreased by -19.76% in one year.
Market Cap
190.85B
Enterprise Value
175.84B
Revenue
56.75B
Ranking
n/a
PE Ratio
19.99
Stock Price
980.00
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 4.20B to 190.85B, an increase of 4,439.98%. That is a compound annual growth rate of 15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 190.85B | -7.15% |
| Dec 31, 2025 | 205.55B | -21.25% |
| Dec 31, 2024 | 261.03B | -14.99% |
| Dec 29, 2023 | 307.05B | -18.16% |
| Dec 30, 2022 | 375.17B | 12.82% |
| Dec 31, 2021 | 332.53B | 4.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Industrias Peñoles | 436.97B |
| Arca Continental | 348.22B |
| FIBRA Prologis | 138.53B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 124.25B |
| Fibra UNO | 109.90B |
| Grupo Elektra | 91.63B |
| Gentera | 82.71B |
| Corporación Moctezuma | 70.57B |